Respiratory disease in very‐low‐birthweight infants after prenatal thyrotropin‐releasing hormone and glucocorticoid
Ballard R, Ballard P, Creasy R, Padbury J, Polk D, Bracken M, Moya F, Gross I. Respiratory disease in very‐low‐birthweight infants after prenatal thyrotropin‐releasing hormone and glucocorticoid. International Journal Of Gynecology & Obstetrics 1992, 39: 163-163. DOI: 10.1016/0020-7292(92)90961-h.Peer-Reviewed Original ResearchPrenatal thyrotropin-releasing hormoneThyrotropin-releasing hormoneBirthweight infantsRespiratory diseaseGlucocorticoidsInfantsDiseaseHormoneRespiratory disease in very-low-birthweight infants after prenatal thyrotropin-releasing hormone and glucocorticoid
Ballard R, Ballard P, Bracken M, Moya F, Gross I, Creasy K, Padbury J, Polk D. Respiratory disease in very-low-birthweight infants after prenatal thyrotropin-releasing hormone and glucocorticoid. The Lancet 1992, 339: 510-515. PMID: 1346877, DOI: 10.1016/0140-6736(92)90337-3.Peer-Reviewed Original ResearchMeSH KeywordsBetamethasoneChronic DiseaseDouble-Blind MethodDrug Therapy, CombinationFemaleHumansInfant, Low Birth WeightInfant, NewbornInfant, Premature, DiseasesLung DiseasesMalePregnancyPrenatal CareRespiration, ArtificialRespiratory Distress Syndrome, NewbornRisk FactorsThyrotropin-Releasing HormoneConceptsChronic lung diseaseThyrotropin-releasing hormoneRespiratory distress syndromePrenatal thyrotropin-releasing hormoneDistress syndromePostconceptional ageBirthweight infantsLung diseaseSevere respiratory distress syndromeSteroid-alone groupNeonatal respiratory morbidityComplications of prematurityUnadjusted relative riskPrenatal glucocorticoid treatmentWeeks postconceptional ageTRH therapyPreterm deliveryRespiratory morbidityWeeks' gestationGlucocorticoid treatmentNeonatal periodAdverse outcomesTotal incidencePrenatal treatmentRelative risk